Trademark: 97670210
Word
CARIS DISCOVERY
Status Date
Tuesday, May 14, 2024
Filing Date
Wednesday, November 9, 2022
Published for Opposition
Tuesday, March 19, 2024
42 Medical and scientific research and analysis services in the field of molecular biology, namely, identification of molecular targets for diagnosis, prognosis, and therapeutics in the field of healthcare; drug discovery services; pharmaceutical drug development services; Application service provider (ASP) featuring software using artificial intelligence for identifying novel targets across exome, transcriptome and cancer proteome to develop precision medicine-based medicines; Providing temporary use of on-line non-downloadable software using artificial intelligence for identifying novel targets across exome, transcriptome and cancer proteome to develop precision medicine-based medicines
Nov 12, 2022
New Application Entered
Nov 30, 2022
New Application Office Supplied Data Entered
Aug 23, 2023
Assigned To Examiner
Aug 30, 2023
Non-Final Action Written
Aug 30, 2023
Non-Final Action E-Mailed
Aug 30, 2023
Notification Of Non-Final Action E-Mailed
Nov 29, 2023
Teas Response To Office Action Received
Nov 29, 2023
Correspondence Received In Law Office
Nov 30, 2023
Teas/Email Correspondence Entered
Jan 1, 2024
Notification Of Non-Final Action E-Mailed
Jan 1, 2024
Non-Final Action Written
Jan 1, 2024
Non-Final Action E-Mailed
Feb 12, 2024
Correspondence Received In Law Office
Feb 12, 2024
Teas/Email Correspondence Entered
Feb 12, 2024
Teas Response To Office Action Received
Feb 28, 2024
Official Gazette Publication Confirmation E-Mailed
Feb 13, 2024
Approved For Pub - Principal Register
Feb 28, 2024
Notification Of Notice Of Publication E-Mailed
Mar 19, 2024
Published For Opposition
Mar 19, 2024
Official Gazette Publication Confirmation E-Mailed
May 14, 2024
Noa E-Mailed - Sou Required From Applicant
May 17, 2024
Teas Statement Of Use Received
Trademark Alertz updated from USPTO on 2030-01-24
